Page 15 - James Kiley News Today : Breaking News, Live Updates & Top Stories | Vimarsana

May 19, 2021 Adding antibiotics to usual care does not improve outcomes for people with the lung disease idiopathic pulmonary fibrosis (IPF), according to the findings from a multi-center, phase 3 clinical trial sponsored by Weill Cornell Medicine. Importantly, the investigators note that although the trial had negative findings, the novel way it was designed and conducted could pave the way for future studies that are less expensive and easier to conduct. The research was published May 11 in JAMA: The Journal of the American Medical Association. “IPF is a rare but fatal disorder that has a prognosis worse than most cancers and, unfortunately, has very limited therapeutic options,” said lead author Dr. Fernando J. Martinez, the Bruce Webster Professor of Internal Medicine at Weill Cornell Medicine and chief of pulmonary and critical care medicine at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center. “There has been a lot of interest in trying to de

United statesUnited kingdomWeill cornellJames kileyFernandoj martinezPresbyterian weill cornell medical centerNational institutes of healthDuke clinical research instituteLakes foundationJournal of the american medical associationDivision of lung diseasesVeracyte incBlood instituteNational heartAmerican medicalBruce webster professor